Interaction of functional FCER2 promoter polymorphism and phenotype-associated haplotypes

Tissue Antigens

Volumn 74, Issue 6, 2009, Pages 534-538

  Potaczek, D P ^a   Wang, Q H ^a,b   Sanak, M ^c   Tokura, T ^a   Matsuda, H ^a   Dziedzina, S ^c   Nakano, N ^a   Hara, M ^a   Ogawa, H ^a   Szczeklik, A ^c   Okumura, K ^a   Nishiyama, C ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

FCER2; Haplotype; Polymorphism; Sp1; Sp3

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ARTICLE; BINDING AFFINITY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN E RECEPTOR GENE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

BINDING SITES; HAPLOTYPES; HUMANS; LECTINS, C-TYPE; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, IGE; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

EID: 70449336475     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01360.x     Document Type: Article

References (10)

1. Hibbert RG, Teriete P, Grundy GJ et al. The structure of human CD23 and its interactions with IgE and CD21. J Exp Med 2005 : 202 : 751 760.
2. Tantisira KG, Silverman ES, Mariani TJ et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 2007 : 120 : 1285 1291.
3. Meng JF, McFall C, Rosenwasser LJ. Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun 2007 : 8 : 215 223.
4. Shen M, Vermeulen R, Rajaraman P et al. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environ Mol Mutagen 2009 : 50 : 285 290.
5. Nishiyama C, Akizawa Y, Nishiyama M et al. Polymorphisms in the FcεRIβ promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between FcεRIβ and atopy. J Immunol 2004 : 173 : 6458 6464.
6. Yokota A, Kikutani H, Tanaka T et al. Two species of human Fcε receptor II (FcεRII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 1988 : 55 : 611 618.
7. Kanada S, Nakano N, Potaczek DP et al. Two different transcription factors discriminate the -315C > T polymorphism of the FcεRI α-chain gene: binding of Sp1 to -315C and of a high mobility group-related molecule to -315T. J Immunol 2008 : 180 : 8204 8210.
8. Haaning Andersen AD, Lange M, Lillevang ST. Allelic variation of the inducible costimulator (ICOS) gene: detection of polymorphisms, analysis of the promoter region, and extended haplotype estimation. Tissue Antigens 2003 : 61 : 276 285.
9. LeVan TD, Bloom JW, Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001 : 167 : 5838 5844.
10. Kim KJ, Lee HJ, Park MH et al. SNP identification, linkage disequilibrium, and haplotype analysis for a 200-kb genomic region in a Korean population. Genomics 2006 : 88 : 535 540.